Page
%P
![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Classifying ultra-high risk smoldering myeloma
-
Article
Association between mobilization regimen and PFS after auto-SCT for multiple myeloma
-
Article
Cellular immunotherapy for plasma cell myeloma
Allogeneic hematopoietic cell transplantation for plasma cell myeloma can lead to graft-vs-myeloma immunity and long-term survivorship, but limited efficacy and associated toxicities have prevented its widespr...